Home › Myasthenia Gravis › Colorado › Aurora
Myasthenia Gravis clinical trials in Aurora, CO
5 studies for Myasthenia Gravis are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
RecruitingPhase 2
- University of Colorado Neuromuscular Division, Aurora
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
RecruitingPhase 1/2
- University of Colorado, Aurora
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
RecruitingPhase 2/3
- Children's Hospital Colorado, Aurora
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RecruitingPhase 3
- University of Colorado Anschutz Medical Campus, Aurora
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RecruitingHealthy volunteers welcome
- University of Colorado Denver, Aurora
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- New York City, NY7 studies
- Milwaukee, WI7 studies
- Miami, FL7 studies
- St. Louis, MO7 studies
- Columbia, MO6 studies
- Dallas, TX6 studies
- Detroit, MI6 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer26 studies
- Metastatic Cancer25 studies
- Ovarian Cancer24 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
- Prostate Cancer17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.